Page last updated: 2024-10-29

ifosfamide and Epithelial Ovarian Cancer

ifosfamide has been researched along with Epithelial Ovarian Cancer in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The aim of this phase II study was to investigate the efficacy and toxicity of combined ifosfamide and cisplatin chemotherapy in patients with recurrent epithelial ovarian cancer (EOC)."5.17Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer. ( Bae, DS; Choi, CH; Kim, BG; Kim, MK; Kim, TJ; Lee, JW; Lee, YY; Song, T, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, T1
Kim, MK1
Lee, YY1
Choi, CH1
Kim, TJ1
Lee, JW1
Kim, BG1
Bae, DS1
Lee, M1
Kim, SW1
Nam, EJ1
Cho, H1
Kim, JH1
Kim, YT1
Kim, S1

Trials

1 trial available for ifosfamide and Epithelial Ovarian Cancer

ArticleYear
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.
    Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplati

2013

Other Studies

1 other study available for ifosfamide and Epithelial Ovarian Cancer

ArticleYear
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
    Yonsei medical journal, 2014, Volume: 55, Issue:6

    Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherap

2014